Antiarrhythmic drugs
Antiarrhythmic drugs are medicines used to treat or prevent heart rhythm problems (arrhythmias). MeSH says they are often sorted into four main groups by how they act on the heart. The US labels for amiodarone, flecainide, propafenone, sotalol, dofetilide and dronedarone call each an antiarrhythmic, and their pages are filed under this class. This is the class page.
Also called Anti-Arrhythmia Agents · Antiarrhythmics · Antiarrhythmic agents
- Drug
- In this atlas
Overview
Technical summary
Class page. MeSH descriptor D000889 (Anti-Arrhythmia Agents) is an exact match. Its scope note names agents for treating or preventing cardiac arrhythmias and sorts them into four main mechanism groups: sodium channel, beta-adrenergic, repolarization and calcium channel. Two US amiodarone labels read (Pacerone tablets, ANDA075135; Nexterone injection, NDA022325) describe amiodarone as an antiarrhythmic and as a class III antiarrhythmic drug that has the electrophysiologic characteristics of all four Vaughan Williams classes, and RxClass lists the established pharmacologic class Antiarrhythmic on US drug labels for it; amiodarone is filed under this page on that evidence, and flecainide, propafenone, sotalol, dofetilide and dronedarone on the RxClass class Antiarrhythmic for each of them. Two of the four MeSH groups, beta-adrenergic and calcium channel blockade, have class pages of their own in this atlas; they are linked, not repeated. Statements are scoped to the labels read. No trial result and no dose is recorded.
Drugs in this class
6 drugs in this atlas are filed under Antiarrhythmic drugs, with the registry trials and FDA regulatory decisions this atlas holds for each. With Antiarrhythmic drugs itself, the class has 20 distinct trials and 5 distinct FDA decisions; a trial or decision that two of them share counts once there.
About this drug
- Level
- Class
- Mechanism
- MeSH lists four main mechanism groups: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation and calcium channel blockade.
Claims and evidence
No claims are published for this drug yet.
Record details
- Record id
cardio:antiarrhythmic-drugs- Content hash
71dac4c4257565dfb749bd4ad0a66f5e954c16e813f2f7530c56943364ce8096